Rare diseases
Investigational molecules
Locations
Tvistevagen 48 C, Alidhem, 907 36 Umea, Sweden
Lipigon Pharmaceuticals AB focuses on clinical research in moderate to severe hypertriglyceridemia, with attention to patients who have elevated plasma triglyceride concentrations and require targeted lipid management.
The sponsor’s trial activity is centered on treatment options for abnormal triglyceride levels, reflecting a clear therapeutic interest in metabolic and cardiovascular risk-related lipid disorders.
Lipigon Pharmaceuticals AB runs clinical trials in conditions such as Hypertriglyceridaemia, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
SwedenIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
